首页> 外文期刊>The American journal of emergency medicine >Consideration for primary angioplasty: impact on the door-to-drug time in AMI patients ultimately treated with thrombolytic agent.
【24h】

Consideration for primary angioplasty: impact on the door-to-drug time in AMI patients ultimately treated with thrombolytic agent.

机译:初次血管成形术的考虑:对最终使用溶栓剂治疗的AMI患者的上门用药时间的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The objective of this study was to determine if consideration for percutaneous transluminal coronary angioplasty (PTCA) delays administration of thrombolytic therapy in acute myocardial infarction (AMI) patients. Retrospective medical record review of patients ultimately diagnosed with AMI who presented to the ED with chest pain and ST segment elevation on the electrocardiogram; these patients also received acute reperfusion therapy (PTCA or thrombolytic agent). AMI was diagnosed by abnormal elevations in the creatinine phosphokinase MB fraction. The study period covered 2 years (July 1, 1994 to June 30, 1996) in a university hospital ED with an annual volume of 60,000 patient-visits. The use of reperfusion therapies, time intervals, and times of presentation were recorded. Patients were divided into two groups based on cardiac catheterization laboratory (CATH) availability: (group I, CATH currently in operation, Monday to Friday, 7 am to 7 pm and group II, CATH currently not in-operation, all other times). Fifty-two patients with AMI met entry criteria. Patients were treated with thrombolytic therapy in 25 cases; PTCA in 27 cases. Patients received thrombolytic agents within statistically equivalent time intervals regardless of the period of presentation; time to thrombolytic therapy for group I patients was 38 +/- 16 minutes compared with 36 +/- 26 minutes for group II patients (P =. 891). A trend toward significance was noted in the use of PTCA compared with thrombolytic agent; Group I patients were more often treated with PTCA (19) compared with group II patients (11, P =.067). Patients were more rapidly treated with PTCA during CATH operation; the mean time to PTCA for group I patients was 73.5 minutes compared with PTCA for group II patients with 107.8 minutes (P =.033). The consideration for PTCA did not significantly delay the administration of thrombolytic therapy at the study site institution. PTCA was initiated more rapidly in patients presenting with AMI during hours of CATH operation.
机译:这项研究的目的是确定在急性心肌梗死(AMI)患者中考虑经皮腔内冠状动脉成形术(PTCA)是否延迟溶栓治疗的给药。对最终诊断为AMI并在心电图上向ED表现为胸痛和ST段抬高的AMI进行回顾性医学记录;这些患者还接受了急性再灌注治疗(PTCA或溶栓剂)。肌酐磷酸激酶MB分数异常升高可诊断为AMI。研究期为2年(1994年7月1日至1996年6月30日),该医院在ED的一所大学医院就诊,每年的患者访问量为60,000。记录再灌注疗法,时间间隔和出现时间。根据心脏导管实验室(CATH)的可用性将患者分为两组:(第一组,CATH目前在手术中,星期一至星期五,上午7点至晚上7点;第二组,CATH当前不在手术中,所有其他时间)。 52名AMI患者符合入组标准。 25例患者接受了溶栓治疗。 PTCA 27例。无论出现的时间长短,患者在统计学上相等的时间间隔内接受溶栓剂治疗; I组患者接受溶栓治疗的时间为38 +/- 16分钟,而II组患者为36 +/- 26分钟(P = 891)。与溶栓剂相比,使用PTCA的趋势明显。与第二组患者(11,P = .067)相比,第一组患者更常接受PTCA治疗(19)。在CATH手术中,患者接受PTCA的治疗更快。 I组患者到达PTCA的平均时间为73.5分钟,而II组患者则为107.8分钟(P = .033)。 PTCA的考虑并没有显着延迟研究地点机构的溶栓治疗的实施。在CATH手术期间,患有AMI的患者可以更快地启动PTCA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号